investor regeneron.com

Investor Relations Latest information on Regeneron Pharmaceuticals

Get the latest Regeneron news and company information including our media kit, earnings, pipeline and product overviews for ARCALYST, EYLEA and PRALUENT.
traffic

OVERVIEW

The website investor.regeneron.com currently has an average traffic ranking of zero (the smaller the higher page views). We have examined nineteen pages inside the domain investor.regeneron.com and found fifty-two websites interfacing with investor.regeneron.com. There is three social networking platforms owned by investor.regeneron.com.
Pages Crawled
19
Links to this site
52
Social Links
3

INVESTOR.REGENERON.COM TRAFFIC

The website investor.regeneron.com has seen a fluctuation amounts of traffic all round the year.
Traffic for investor.regeneron.com

Date Range

1 week
1 month
3 months
This Year
Last Year
All time
Traffic ranking (by month) for investor.regeneron.com

Date Range

All time
This Year
Last Year
Traffic ranking by day of the week for investor.regeneron.com

Date Range

All time
This Year
Last Year
Last Month

LINKS TO DOMAIN

WHAT DOES INVESTOR.REGENERON.COM LOOK LIKE?

Desktop Screenshot of investor.regeneron.com Mobile Screenshot of investor.regeneron.com Tablet Screenshot of investor.regeneron.com

INVESTOR.REGENERON.COM SERVER

I observed that a lone page on investor.regeneron.com took six hundred and twenty-one milliseconds to stream. I could not observe a SSL certificate, so in conclusion our web crawlers consider this site not secure.
Load time
0.621 secs
SSL
NOT SECURE
Internet Protocol
206.200.251.19

BROWSER IMAGE

HTML TITLE

Investor Relations Latest information on Regeneron Pharmaceuticals

DESCRIPTION

Get the latest Regeneron news and company information including our media kit, earnings, pipeline and product overviews for ARCALYST, EYLEA and PRALUENT.

PARSED CONTENT

The website investor.regeneron.com states the following, "Regeneron NASDAQ REGN is a leading science and technology company delivering life-transforming medicines for serious diseases." We viewed that the webpage also said " Our robust research and development engine allows us to discover therapies that could have a profound impact on patient health." It also said " Our goal is to address serious medical conditions, across multiple and diverse therapeutic areas. Our FDA-approved medicines are only the beginning of our long-term commitment to solve the human bodys most complex mysteries." The header had Regeneron as the highest ranking search term. This keyword is followed by investors, media, and recent news which isn't as urgent as Regeneron. The other words they used was news releases. press releases is included but will not be viewed by web engines.

SEEK SUBSEQUENT DOMAINS

Renewable Energy Group, Inc. - Investor Relations

We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put Renewable Energy Group, Inc. Renewable Energy Group Announces Changes to Board of Directors. Renewable Energy Group Reports Fourth Quarter and Full Year 2017 Financial Results.

Investor Relations Investor Relations Regal Theatres

Regal Entertainment Group Reports Results for Fiscal Second Quarter 2015 and Declares Quarterly Dividend. Regal Entertainment Group Announces Timing of Fiscal Second Quarter 2015 Earnings Release and Conference Call. Regal Entertainment Group to Participate in Investor Conference in New York.

Investor Relations Reis, Inc.

Announces Fourth Quarter and Full-Year 2017 Financial Results. Fourth Quarter 2017 Financial Results Call. 20th Annual Needham Growth Conference. View all events and presentations. 1185 Avenue of the Americas. New York, NY 10036.

Company Overview RenaissanceRe

Tropical Cyclone Forecasting And Risk Analysis. The RenaissanceRe Wall of Wind.